2021
DOI: 10.51893/2021.4.oa2
|View full text |Cite
|
Sign up to set email alerts
|

Protocol summary and statistical analysis plan for the Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…An arterial blood gas measure should then be performed as soon as possible after hospital arrival to ensure that P co 2 is in the normal range. Of note, a phase 3 study testing whether mild hypercapnia (P co 2 of 50-55 mm Hg) improves outcomes compared with normocapnia after resuscitation from out-of-hospital cardiac arrest has recently concluded, and the results of that study are awaited with interest.…”
mentioning
confidence: 99%
“…An arterial blood gas measure should then be performed as soon as possible after hospital arrival to ensure that P co 2 is in the normal range. Of note, a phase 3 study testing whether mild hypercapnia (P co 2 of 50-55 mm Hg) improves outcomes compared with normocapnia after resuscitation from out-of-hospital cardiac arrest has recently concluded, and the results of that study are awaited with interest.…”
mentioning
confidence: 99%
“…The trial protocol and statistical analysis plan were published before the completion of enrollment. 27 All the analyses were performed in the intention-to-treat population, which included all the patients who had undergone randomization except for those who withdrew consent.…”
Section: Discussionmentioning
confidence: 99%
“…These possibilities also include manual chest compression and bag mask ventilation. Whether mild hypercapnia (PaCO 2 50-55 mm Hg) within the first 24 h after OHCA is associated with a favorable neurological survival after six months is currently being investigated in the Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) trial [67]. These findings can impact future initial ICU treatment and are awaited to be published in June 2023.…”
Section: Discussionmentioning
confidence: 99%